CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 24,500 shares, an increase of 49.4% from the February 28th total of 16,400 shares. Approximately 2.3% of the shares of the stock are short […]
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 24,500 shares, a growth of 49.4% from the February 28th total of 16,400 shares. Based on an average trading volume of 42,400 shares, the […]
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 528,500 shares, an increase of 80.6% from the May 15th total of 292,600 shares. Based on an average trading volume of 854,300 shares, the […]
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 291,000 shares, a decline of 46.3% from the February 28th total of 541,900 shares. Currently, 1.6% of the shares of the company are short sold. Based on […]